Photo detail

Mike Grey is the CEO of Mirum Pharmaceuticals, which formed around revitalizing the liver drug maralixibat. Photo courtesy of Lumena

Stories this photo appears in:

Mirum Team Is on Familiar Ground With Liver Drug Effort

In 2014, pharmaceutical Shire bought San Diego company Lumena and its lead drug candidate, called maralixibat. Now maralixibat is back in the hands of former Lumena talent.

Tease photo